Why Is Insmed Stock Trading Higher Today - Insmed (NASDAQ:INSM)

Insmed’s lung disease drug approved in the U.S.

Insmed will market the daily pill, brensocatib, under the brand name Brinsupri and expects to see billions in sales.

Why Is Insmed Stock Trading Higher Today - Insmed (NASDAQ:INSM)

The U.S. Food and Drug Administration (FDA) on Tuesday approved Insmed Incorporated’s (NASDAQ:INSM) Brinsupri (brensocatib 10 mg and 25 mg tablets). It is an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and children 12 years and older. Brinsupri is the first and only FDA-approved treatment for NCFB, a chronic lung condition characterized by permanently widened and damaged airways (bronchi), leading to persis…